Zhou, Tianxing
Xie, Yongjie
Hou, Xupeng
Bai, Weiwei
Li, Xueyang
Liu, Ziyun
Man, Quan
Sun, Jingyan
Fu, Danqi
Yan, Jingrui
Zhang, Zhaoyu
Wang, Yifei
Wang, Hongwei
Jiang, Wenna
Gao, Song
Zhao, Tiansuo
Chang, Antao
Wang, Xiuchao
Sun, Hongxia
Zhang, Xiufeng
Yang, Shengyu
Huang, Chongbiao
Hao, Jihui
Liu, Jing
Funding for this research was provided by:
the Key Technologies Research and Development Program (2021YFA1201100)
the National Natural Science Foundation of China (82072716, 81802433, 82030092, 81720108028, 82072659, 81871968, 81871978, 82103006)
the National Natural Science Foundation of China (82072657)
the National Natural Science Foundation of China (82173295)
Tianjin Natural Science Foundation (20JCQNJC01330)
Tianjin Research Innovation Project for Postgraduate Students (2021YJSB262)
Collaboration Program of Beijing Tianjin and Hebei (22JCZXJC00120)
Article History
Received: 20 November 2022
Accepted: 10 April 2023
First Online: 4 May 2023
Declarations
:
: The usage of these specimens and the patients’ information were approved by the Ethics Committee of the Tianjin Medical University Cancer Institute and Hospital (Tianjin, China) and the Ethics Committee of the Tongliao City Hospital (Tongliao, China). All patients provided written consent for the use of their specimens and disease information for future investigations according to the ethics committee and in accordance with recognized ethical guidelines of Helsinki (ID number of the ethics approval: AE-2021121 and 2021024).
: The content of this paper has not been submitted to any other scientific publications. All the authors have declared that no financial conflict of interest exists. All authors of this interdisciplinary team have approved the submission of this work for publication in Journal of Experimental & Clinical Cancer Research.
: The authors have declared that no conflict of interest exists.